跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,098 条关于
“Focal adhesion kinase (FAK)”
全部
13,098
临床试验
9,879
药物
876
机构
62
资讯
2,281
去年
InxMed's Ifebemtinib Receives Breakthrough Therapy Designation for NSCLC with KRAS G12C Mutation
2个月前
Ifebemtinib Plus Garsorasib Shows 82% ORR and 22-Month PFS in First-Line KRAS G12C-Mutant NSCLC
去年
Verastem Oncology Seeks FDA Approval for Avutometinib and Defactinib Combination in Low-Grade Serous Ovarian Cancer
9个月前
Amplia Therapeutics Secures U.S. Patent Protection for FAK Inhibitor Narmafotinib Through 2040
去年
FDA Greenlights Amplia's Protocol for Narmafotinib-FOLFIRINOX Combination Trial in Advanced Pancreatic Cancer
去年
Verastem Oncology to Present New LGSOC Treatment Data at SGO 2025 Annual Meeting
6个月前
FAK Inhibition Unlocks Immune Response Against Treatment-Resistant Ovarian Cancer
去年
Verastem Oncology's RAMP 203 Trial Shows Encouraging Initial Data for Triplet Combination in Advanced KRAS G12C Mutant NSCLC
去年
AVMA Veterinary Clinical Trials Registry Highlights New Studies in Canine and Feline Oncology and Neurological Disorders
去年
Verastem Oncology Refinances Debt and Advances Avutometinib/Defactinib Combination
第 1 页，共 229 页
上一页
下一页
